CSF2 and neoplasm: To verify whether the combined cancer vaccine co-expressing anti-PD-1 mAbs and GM-CSF can induce tumor growth inhibition in vivo, we formulated a therapeutic regimen (Figure 3a) for CT26 and B16-F10 tumor model separately.